World Obesity Day

March 4: World Obesity Day

Obesity is a complex interaction of different factors, for different people, in different countries and cultures. One universal strategy for every person is never going to be the solution. That’s why this year’s World Obesity Day is opening up a wider conversation.

March 4: World Obesity Day Read More »

Clinical Studies on Metabolic Conditions

MLM Drs. Ben Curry and Lisa Jennings Published in the August Issue of the Journal of Thrombosis and Thrombolysis

MLM is an industry leader in platelet function testing and incorporating these types of assays in clinical trials. Our recent work evaluating the pharmacodynamic effects of two anti-platelet drugs currently in clinical development has been published in the Journal of Thrombosis and Thrombolysis.

MLM Drs. Ben Curry and Lisa Jennings Published in the August Issue of the Journal of Thrombosis and Thrombolysis Read More »

CRO Vial Alliance with MLM Medical Labs

Vial Announces Collaborative Alliance with MLM Medical Labs

SOURCE: VIAL / PRNEWSWIRE Full Press Release  SAN FRANCISCO, Sept. 14, 2023 /PRNewswire/ — Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with MLM Medical Labs (“MLM”), an international central and specialty laboratory with locations in Europe and North America. MLM will provide Vial with central laboratory solutions, including study setup management, sample analysis, proprietary MLM Kit Building®

Vial Announces Collaborative Alliance with MLM Medical Labs Read More »

Preclinical Planning and Study Startup

Understanding the Importance (and Unleashing the Power) of Preclinical Study Design: MLM Medical Labs’ Dynamic Approach 

by Katie Dineen, Preclinical Business Development Manager @ MLM Medical Labs Welcome to the realm of preclinical study design, where every choice holds the key to scientific triumph!   In this blog post, we’ll dive into the world of best practices, unlocking the secrets to effective preclinical studies.  Join us as we explore how MLM Medical

Understanding the Importance (and Unleashing the Power) of Preclinical Study Design: MLM Medical Labs’ Dynamic Approach  Read More »

MLM Medical Lab Announces Optimized IPF Disease Model

MLM Medical Labs Launches Optimized IPF Preclinical Model, Achieving Reduced Mortality Rates

We are thrilled to announce the launch of our newly optimized IPF (Idiopathic Pulmonary Fibrosis) preclinical disease model. This model release is positioned to expand research opportunities in the fight against lung disease, providing researchers with an advanced tool to unlock new insights and accelerate the quest for effective treatments. Most remarkable about this optimization

MLM Medical Labs Launches Optimized IPF Preclinical Model, Achieving Reduced Mortality Rates Read More »

MC903 Atopic Dermatitis Model

MLM Medical Labs Introduces Newly Validated MC903 Atopic Dermatitis Model for Preclinical Research

We are extremely excited to announce the successful validation of the MC903 Atopic Dermatitis Model. This preclinical model, the 62nd in MLM’s growing lineup of validated models, provides an ideal solution for companies involved in translational and preclinical research in the field of atopic dermatitis. Atopic dermatitis, a prevalent chronic inflammatory skin condition, presents significant

MLM Medical Labs Introduces Newly Validated MC903 Atopic Dermatitis Model for Preclinical Research Read More »

High Throughput Digital Pathology Scanner

High Throughput Digital Scanner Marks Significant Advancement in MLM’s Digital Pathology Capabilities

Cutting-Edge, High Throughput Technology Enhances and Accelerates Research Capabilities: MLM Medical Laboratories Acquires Leica Biosystems Aperio GT-450 Scanner We are pleased to announce a very significant expansion of our already robust Histology capabilities with the recent acquisition of the state-of-the-art Leica Biosystems Aperio GT-450 Scanner.  This cutting-edge digital pathology solution will revolutionize MLM’s capabilities in

High Throughput Digital Scanner Marks Significant Advancement in MLM’s Digital Pathology Capabilities Read More »

hidradenitis suppurativa, MLM Medical Labs, Dermatology Research

MLM Participates in Important Non-Inverventional Hidradenitis Suppurativa (HS) Study

MLM Medical Labs Supports Leading Biotech Company in a Non-Interventional Hidradenitis Suppurativa (HS) Study MLM Medical Labs – Minneapolis recently partnered with a leading biotech company on the CSL324 study of a novel, fully human anti-G-CSF receptor (G-CSFR) monoclonal antibody in the treatment of hidradenitis suppurativa (HS).  CSL324 is being investigated as a potential treatment in

MLM Participates in Important Non-Inverventional Hidradenitis Suppurativa (HS) Study Read More »